CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Jun. 28, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net (loss) income	$ (17,613)	$ 60,889
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	16,458	14,273
Amortization of deferred financing costs	781	34
Deferred income taxes	(4,999)	(8,362)
Stock-based compensation	10,118	11,042
Loss on disposal of assets	14	0
Provisions for inventory and expected credit losses	2,377	5,183
Change in fair value of marketable securities	0	3,651
Changes in operating assets and liabilities:
Trade accounts receivable	55,134	(10,321)
Inventories	(15,986)	(27,947)
Prepaid expenses and other assets	(1,715)	(10,200)
Trade accounts payable	200	18,431
Due to and from related parties	3,437	10,102
Accrued expenses and other current and long-term liabilities	(14,010)	(17,112)
Net cash provided by operating activities	34,196	49,663
Cash flows from investing activities:
Purchases of property, plant and equipment	(10,977)	(44,910)
Sales of marketable securities	0	9,971
Net cash used in investing activities	(10,977)	(34,939)
Cash flow from financing activities:
Finance lease payments	(145)	0
Receipts on related party notes receivable	938	938
Payments for taxes related to net share settlement of equity awards	(11,171)	(12,422)
Proceeds from issuance of common stock under employee stock purchase plan	0	1,899
Payments of debt issuance costs	0	(1,450)
Net cash used in financing activities	(60,378)	(11,035)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(825)	(73)
Net (decrease) increase in cash and cash equivalents and restricted cash	(37,984)	3,616
Cash and cash equivalents and restricted cash at beginning of period	222,161	358,705
Cash and cash equivalents and restricted cash at end of period:	184,177	362,321
2023 Term Loan Facility
Cash flow from financing activities:
Payment of borrowings under 2023 term loan facility	$ (50,000)	$ 0